medtronic bills itself as kind of an artificial pancreas. dexcom dipped 4% on the news although most of the analysts suggested that medtronic's device was unlikely to take much market share from dexcom. then on november 1, dexcom reported a quarter that left investors feeling very discouraged. the headline numbers weren't too bad. a small revenue beat coupled with a larger than expected leerngz loss. but the commentary on the conference call got people very worried. right from the beginning, the incredibly transparent ceo kevin sayer started talking about, quote, recent developments in the u.s. competitive landscape, end quote. he said the fda's recent approval of medtronic's device was creating, quote, considerable confusion, end quote and implied that so called artificial pancreas was being overhyped. however, sayer also told us many patients had been delaying their purchase decisions for systems until medtronic's new system became available. on top of that, dexcom indicated they would only hit the mid-to high point of their full year reve

then got very concerned because of medtronic because that's a powerful company. then got really shocked about this designation. why don't you give us the timeline and what it means for all the people who are going to be able to use the device. >> well, i was as shocked as you were. >> you were? really, you didn't know? >> we had heard wind early in the week something might be happening and things started quickly towards when the approval was announced. >> you thought it was going to be a year too. >> i was at jpmorgan telling people 2018. >> at the conference you were telling that. that's incredible. >> so it's going to be wrong. it was really good to be wrong. and this is a huge event. you know, i get e-mails continually from 64-year-olds who have had continuous glucose monitoring technology in their lives, taking care of them for a long time, and they write in and say, what happens to me next month? and i don't have anv answer. we have one now. we'll be ail to go to that senior population and the way the wordage is written, it appears to cover type 1 and type 2

medtronic declined to comment to us. to bring you an update on where apple is trading. up 2.5%. let's wrap up some of the data points. beating expectations. .iphone record revenue strong growth in services. solid all around. coming up, what you need to know for tomorrow's trading day. this is bloomberg. ♪ scarlet: we are looking ahead. you don't want to miss this. president trump it acted to announce his nominee to the supreme court tonight. bloomberg will have live coverage. both finalists have been summoned to washington. giving theresa may authority to trigger brexit. finally, facebook earnings reported after the bell tomorrow. should be very exciting. did yous it for what miss. this is bloo >> you are watching bloomberg technology. let's start with a check of your first word news. betsy devos has been approved for education secretary. partisan lines to support her nomination. a senate panel voted for linda mcmahon to lead the small business administration. both nominations move to the full senate for consideration. m

and working with medtronic to predict the highs and lows of diabetes, hours in advance.nd i am working with orreco to use biomarker data to boost the performance of athletes. hello, my name is watson. working together, we can outthink anything. >>> welcome back. panelists here. nbc news michael steele, and kimberley strassel, and i thought it summed up pretty well in "the washington post" where he said this week was everything trump supporters could have hoped for and everything trump's opponents could have feared. kimberly strassel, what say you? >> this is a president that will fulfill all of his campaign promises and take action. this is also a president who sometimes allows his own missteps to get in the way of his successes. he did a lot of stuff this week that was important and good for the economy, but some of it was overshadowed by back and forth over attendance and crowds and voter fraud and diplomatic tiff with mexico and we'll see if there is any greater discipline going forward. >> discipline, tom don't know, but then again donald trump doesn't mind the chaos

and in minneapolis, bill george, former medtronics ceo, former exxonmobil board member, of course a cnbctributor. good morning, guys. >>> our first story is amazon today, announcing it will create more than 100,000 new full-time, full-benefit jobs across the u.s. over the next year and a half. our deidra bosa is at one market with more on that. hey, deirdre. >> good morning, guys. amazon was already on track to become one of the largest employers in the country and this announcement confirms that trajectory. the company emphasized that the opportunities will be for people across the country and with all types of experience, education and skill levels. ceo jeff bezos says "these jobs are not just in our seattle headquarters or in silicon valley. they're in our customer service network, fulfillment centers and other communities throughout the country." that is an important point, because of course, trump has made jobs his focus and the tech industry can be known for making a lot of money with a smaller workforce than say the manufacturing sector. it may also be an opportune announcement. m

and working with medtronic to predict the highs and lows of diabetes, hours in advance. and i am working with orreco to use biomarker data to boost the performance of athletes. hello, my name is watson. working together, we can outthink anything. our partners at kensho say if the history of milestones tells us anything, it's that the run isn't done. when the dow has passed major milestones in the past, u.s. markets generally trade up in the quarter that follows. the dow shows a mean return of almost 7%. the s&p jumps 5%. now back to scott wapner and the "halftime" team. >> wed bush is the only firm on the street that doesn't happen to be expecting much. a sell rating, the only you'll mind. james, welcome. >> thanks, scott. >> you want to tell me what the major issue is here? i know we have debated this before. but what's wrong with this company's stock right now that has you with a sell rating and the only one on wall street? >> well, in part, you could say if you have 40 odd analysts covering a stock and there's only one who thinks it's going to underperform, the market

and working with medtronic to predict the highs and lows of diabetes, hours in advance.ith orreco to use biomarker data to boost the performance of athletes. hello, my name is watson. working together, we can outthink anything. >>> welcome back. the icr annual retail conference brings together financial professionals across the world to exchange insights in current consumer and economic trends. our own sara eisen is at the conference in sunny orlando. she joins us with a special guest. sarah? >> kelly, good afternoon. i'm here with patrick doyle, the ceo of dominos. he just arrived. presenting tomorrow. always nice to talk to you. >> thank you, sara. >> we look at the stock performance of dominos double since 2009. we're talking to investors and they want to know from you, can you keep doing it? >> first, knock on wood, right? it's been a good few years. and i think we've done some things that have been a little different than a lot in the industry. we've really focused hard on the long term. so not a lot of ltos, not a lot of just new products for new product sake to ge

we are joined this morning by former medtronics ceo, bill george.o the former deputy secretary for international trade at the u.s. treasury, gary. good to see you both. bill, we had a long discussion in the last hour about the decisions to move capacity is a big one. it takes place over many years. boards take it seriously. how much can the white house move that needle and how fast? >> well, as i said in my article last week in "fortune," this is good politics and poor economics. long term, the manufacturers have to have a global mother and father -- manufacturing plan and have to make things economically. they can't make small cars in the united states if they'll lose money. i think there is going to be a lot of rethinking about this. i agree with speaker ryan. we need to fix the tax system. we can fix the repatriation tax and bring back tens if not hundreds of billions of dollars into the united states and tell the manufacturers they have to reinvest in the u.s. i think that would be a huge boom. just trying to put border taxes on and punishing pe

and working with medtronic to predict the highs and lows of diabetes, hours in advance.working with orreco to use biomarker data to boost the performance of athletes. hello, my name is watson. working together, we can outthink anything. hello, my name is watson. what witi'm stressed,e horse? trying to figure out this complex trade so i brought in my comfort pony. well you could get support from thinkorswim's in-app chat so you don't need a comfort pony. so what about my motivational meerkat? in-app chat on thinkorswim. only at td ameritrade. [phone buzzing] some things are simply impossible to ignore. the strikingly designed lexus nx turbo and hybrid. the suv that dares to go beyond utility. this is the pursuit of perfection. whyour boss?ork for? yourself? your family? our financial advisors are free to realize a plan to fit your family's unique needs. we'll listen. we'll talk. we'll plan. baird. fnchlths you thought this week was busy for earnings, next week we have all kinds of corporate earnings coming out. what stock may be the best buy, best results? let's ask our t

and working with medtronic to predict the highs and lows of diabetes, hours in advance. am working with orreco to use biomarker data to boost the performance of athletes. hello, my name is watson. working together, we can outthink anything. hwe're drowning in information. where, in all of this, is the stuff that matters? the stakes are so high, your finances, your future. how do you solve this? you don't. you partner with a firm that advises governments and the fortune 500, and, can deliver insight person to person, on what matters to you. morgan stanley. >>> yes, yes. a lot still ahead on "squawk box" this morning. up next, investing in the trump era. stock picks from value investor mario gabelli. later, getting in the game. we'll talk to mlb commissioner rob manfred about the pace of play and that meeting he had with president trump. stick around. "squawk box" will be right back. >>> welcome back to "squawk box." our next guest is one of wall street's first big voices to come out and predict the trump victory as early as last year. joining us is mario gabelli. you like